BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11426568)

  • 1. Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide.
    Bohgaki T; Notoya A; Kondo M; Mukai M; Kohno M
    Leuk Lymphoma; 2001 Jan; 40(3-4):433-6. PubMed ID: 11426568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low dose continuous infusion therapy with etoposide (VP-16) and cytosine arabinoside (Ara-C) for a patient with refractory acute myelogenous leukemia].
    Koyama S; Itou S; Shibata A
    Rinsho Ketsueki; 1990 Nov; 31(11):1891-2. PubMed ID: 2287079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
    Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
    Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
    Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].
    Matsue K; Tohi T; Masauji N; Tsukuda K
    Rinsho Ketsueki; 1992 Mar; 33(3):338-42. PubMed ID: 1578638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.
    Pina-Oviedo S; Torres-Cabala CA; Miranda RN; Tetzlaff MT; Singh S; Rapini RP; Prieto VG; Aung PP
    Am J Dermatopathol; 2017 May; 39(5):388-392. PubMed ID: 27759701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuation of complete remission by oral administration of cytarabine ocfosfate in a patient with M0, who achieved remission by small doses of cytosine arabinoside with G-CSF].
    Aoki S; Koyama S; Goto T; Takahashi H; Shibata A
    Rinsho Ketsueki; 1995 Jan; 36(1):40-4. PubMed ID: 7536275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute myeloblastic leukemia showing pronounced skin infiltration during administration of low-dose cytarabine and etoposide with granulocyte colony-stimulating factor].
    Kawachi Y; Kuwajima Y; Nishihara T; Uchida T; Setsu K; Mori M; Ikeda K; Ikeda T; Sasaki K; Takahara J
    Rinsho Ketsueki; 1997 Sep; 38(9):763-9. PubMed ID: 9364868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
    Yamamoto K; Nagata K; Morita Y; Hamaguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acantholytic dermatosis and leukemia cutis: cause or effect?
    Sakalosky PE; Fenske N; Morgan MB
    Am J Dermatopathol; 2002 Jun; 24(3):257-9. PubMed ID: 12140444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].
    Tsukaguchi M; Furukawa Y; Kitani T
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1603-7. PubMed ID: 9725056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.
    Vogler WR; McCarley DL; Stagg M; Bartolucci AA; Moore J; Martelo O; Omura GA
    Leukemia; 1994 Nov; 8(11):1847-53. PubMed ID: 7967730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated.
    Chaoui D; Peffault De Latour R; Legrand O; Marie JP
    Leuk Lymphoma; 2005 Mar; 46(3):401-4. PubMed ID: 15621830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients.
    Hartmann F; Jacobs G; Gotto H; Schwamborn J; Pfreundschuh M
    Leuk Lymphoma; 2001 Jul; 42(3):347-55. PubMed ID: 11699399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia].
    Takasaki H; Tachibana T; Tanaka M; Maruta A; Ishigatsubo Y; Kanamoari H
    Rinsho Ketsueki; 2010 May; 51(5):339-44. PubMed ID: 20534955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
    Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
    Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.